Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: SnowShredder who wrote (822)	9/5/2001 11:15:22 AM
From: tuck	Read Replies (1) \| Respond to of 1784

WHG, >>I consider FSH a competitor to IVGN & VWR...in selling some lab supplies...bwdik?<< In the early days of the thread somebody made exactly that comparison; I think it was tommysdad. The problem is that FSH breaks out revenue geographically, not by market segment. I know they sell to industrial customers, but i don't know if the non life science revenue accounts for more than half. This munch continues the mystery. I suppose I should call IR. Trickle notes WAT and CALP favored with nice analyst recos today. CALP, in particular could use a boost. Cheers, Tuck